Ex Parte Haas - Page 5


                 Appeal No.  2005-1738                                                          Page 5                    
                 Application No. 10/046,897                                                                               

                         The examiner relies on paragraph 46 of Shibata, which teaches that “[t]he                        
                 method of giving it is either oral or non-oral administration.  As non-oral                              
                 administration, intramuscular, intra stomach, transdermal, nasal and vein                                
                 administration can be used.”  The examiner asserts that                                                  
                         [t]he reference as translated states that the hops extract can be                                
                         applied transdermally or to the skin to treat a pathogenic                                       
                         Staphylococcus aureus infection.  The reference as translated does                               
                         not specify that the transdermal administration is performed using a                             
                         medicated patch or a syringe.  In addition, a person of any degree                               
                         of skill in the pharmaceutical art would appreciate that syringe                                 
                         injection is not transdermal administration.  Transdermal                                        
                         administration means that the active substance is absorbed through                               
                         the skin.  Syringe injection pierces the skin; thus it is not                                    
                         administration through the skin.  Thus, the appellants conjecture                                
                         regarding the teaching of the reference to administer by injection or                            
                         medicated patch is outside any suggestion of the reference’s                                     
                         teaching of transdermal administration.                                                          
                 Examiner’s Answer, pages 6-7 (emphasis in original).                                                     
                         The examiner, however, is ignoring paragraph 45, the paragraph directly                          
                 before the relied upon paragraph, which states “[t]he amount to be administered                          
                 varies in a range from 0.001 mg/body weight kg/day ~ 100 g/body weight kg/day                            
                 in the original weight of galenicals.  An amount of an agent for prevention is                           
                 different from that of the agent for treatment, and generally the amount to be                           
                 administered is larger for the latter.”  Thus, that paragraph would not suggest to                       
                 the ordinary artisan that the galenical is to be used to wash the teat or udder to                       
                 prevent mastitis.                                                                                        
                         Finally, the examiner is not giving any weight to the Translation Certificate,                   
                 attached as Exhibit B to the Appeal Brief, wherein the translator declares, under                        
                 the penalty of perjury, that “[t]he word, transdermal, is used Interchangeably with                      





Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007